07:00 , May 19, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Cancer Acute myeloid leukemia (AML) Histone methyltransferase DOT1L (DOT1L); myeloid-lymphoid or mixed-lineage leukemia translocated to 3 (MLLT3; AF9) Mouse studies suggest inhibiting...